Goldman Sachs’s Adient ADNT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADNT
HHAM
Goldman Sachs's ADNT Position: Q2 2026 in Review
Goldman Sachs reduced its Adient (ADNT) stake by 35% in Q2 2026, selling an estimated $16.7M and leaving 1,432,916 shares worth $26.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2383.
Goldman Sachs first reported a position in ADNT in Q4 2016 and has held it in 39 quarters since. The position peaked at $112M in Q2 2021. 313 funds tracked by Wall St. Rank hold ADNT as of Q2 2026.
- Goldman Sachs held 1,432,916 shares of Adient worth $26.3M as of Q2 2026.
- Goldman Sachs sold 780,794 Adient shares in Q2 2026, an estimated $16.7M.
- Adient made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #2383 holding.
- Goldman Sachs first reported a position in Adient in Q4 2016 and has held it in 39 quarters since.
- Goldman Sachs's Adient position peaked at $112M in Q2 2021.
- 313 funds tracked by Wall St. Rank held Adient as of Q2 2026.
Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.